FDA Inspection
Tris Pharma Inc.Tris Pharma Inc. – FDA Inspection, Jan 21, 2014
Record Details
This FDA Inspection record concerns Tris Pharma Inc., with an inspection on January 21, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Tris Pharma Inc.
- Inspection Date
- January 21, 2014
- Product Type
- Drugs
View Company Profile
ID · 6a3b02df-b591-43de-94af-fb1f34167b98
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 862272
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Tris Pharma Inc.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
| March 8, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 8, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 16, 2018 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for Tris Pharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.